Arix Bioscience (LSE:ARIX) Additional Paid-In Capital : £188.53 Mil(As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Arix Bioscience Additional Paid-In Capital?

Arix Bioscience's quarterly additional paid-in capital increased from Jun. 2022 (£0.00 Mil) to Dec. 2022 (£188.53 Mil) but then stayed the same from Dec. 2022 (£188.53 Mil) to Jun. 2023 (£188.53 Mil).

Arix Bioscience's annual additional paid-in capital stayed the same from Dec. 2020 (£188.53 Mil) to Dec. 2021 (£188.53 Mil) and stayed the same from Dec. 2021 (£188.53 Mil) to Dec. 2022 (£188.53 Mil).

Arix Bioscience Additional Paid-In Capital Historical Data

The historical data trend for Arix Bioscience's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arix Bioscience Additional Paid-In Capital Chart

Arix Bioscience Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Additional Paid-In Capital

Get a 7-Day Free Trial

188.53

Arix Bioscience Semi-Annual Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Additional Paid-In Capital	Get a 7-Day Free Trial								-	188.53	-	188.53	188.53

Arix Bioscience Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Arix Bioscience Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Arix Bioscience's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Arix Bioscience (LSE:ARIX) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arix Bioscience PLC (LSE:ARIX) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

N/A

Address

50 Duke Street, Duke Street House, London, GBR, W1K 6JL

Website

https://www.arixbioscience.com

Arix Bioscience PLC is a healthcare and life science company. Its business model is to source, finance, and develop healthcare and life science businesses that deliver or seek to deliver therapies to patients. Its segment includes sourcing, financing, and developing healthcare and life science businesses globally.

Arix Bioscience (LSE:ARIX) Headlines

No Headlines